Security key
09075P204
BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (BTAI)
CUSIP: 09075P204
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 21,847,524
- Total 13F shares
- 378,983
- Share change
- +378,936
- Total reported value
- $769,811
- Price per share
- $2.03
- Number of holders
- 31
- Value change
- +$769,716
- Number of buys
- 29
Report period
Q1 2025
Institutions
31
Top holders
10
BTAI full security history
Newer quarter: Q2 2025
BioXcel Therapeutics, Inc. SEC filings
BioXcel Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09075P204
Recent filing periods:
Top shareholders of BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
13D/G
|
Company |
5%
from 13D/G
|
4,315,000
|
$1,613,379 | — | 31 Dec 2024 | |
| Oaktree Capital Group Holdings GP, LLC |
13D/G
|
Oaktree Capital Holdings, LLC |
2.7%
|
170,230
|
$28,939 | -$434,154 | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
4.7%
|
1,276,893
|
$477,558 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.4%
|
1,187,466
|
$444,112 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
1.4%
|
380,608
|
$142,309 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
311,965
|
$116,667 | — | 31 Dec 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.73%
|
199,010
|
$74,410 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.39%
|
104,972
|
$39,249 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.29%
|
77,900
|
$29,127 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.28%
|
77,149
|
$28,846 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.27%
|
73,909
|
$27,635 | — | 31 Dec 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.27%
|
72,046
|
$26,938 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.2%
|
52,952
|
$19,751 | — | 31 Dec 2024 | |
| Alpha Zero LLC |
13F
|
Company |
0.19%
|
52,350
|
$19,574 | — | 31 Dec 2024 | |
| Arete Wealth Advisors, LLC |
13F
|
Company |
0.15%
|
40,500
|
$15,000 | — | 31 Dec 2024 | |
| DIVERSIFY WEALTH MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
40,000
|
$15,092 | — | 31 Dec 2024 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.15%
|
39,368
|
$14,720 | — | 31 Dec 2024 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.14%
|
38,050
|
$14,000 | — | 31 Dec 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.13%
|
34,531
|
$12,911 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.1%
|
25,796
|
$9,645 | — | 31 Dec 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.09%
|
25,505
|
$9,000 | — | 31 Dec 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.09%
|
23,343
|
$8,728 | — | 31 Dec 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.07%
|
18,116
|
$6,774 | — | 31 Dec 2024 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.06%
|
17,316
|
$6,474 | — | 31 Dec 2024 | |
| Virtu Financial LLC |
13F
|
Company |
0.06%
|
16,983
|
$6,000 | — | 31 Dec 2024 | |
| Point72 Asia (Singapore) Pte. Ltd. |
13F
|
Company |
0.06%
|
15,939
|
$5,960 | — | 31 Dec 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.05%
|
14,875
|
$5,503 | — | 31 Dec 2024 | |
| LPL Financial LLC |
13F
|
Company |
0.05%
|
14,544
|
$5,438 | — | 31 Dec 2024 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0.05%
|
12,701
|
$4,749 | — | 31 Dec 2024 | |
| Engineers Gate Manager LP |
13F
|
Company |
0.04%
|
11,985
|
$4,481 | — | 31 Dec 2024 | |
| DAVENPORT & Co LLC |
13F
|
Company |
0.04%
|
11,810
|
$4,416 | — | 31 Dec 2024 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.04%
|
11,800
|
$4,412 | — | 31 Dec 2024 | |
| SeaCrest Wealth Management, LLC |
13F
|
Company |
0.04%
|
11,150
|
$4,169 | — | 31 Dec 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.02%
|
4,819
|
$1,802 | — | 31 Dec 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.02%
|
4,262
|
$1,594 | — | 31 Dec 2024 | |
| Washington Trust Advisors, Inc. |
13F
|
Company |
0.01%
|
2,572
|
$962 | — | 31 Dec 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
2,321
|
$868 | — | 31 Dec 2024 | |
| Parkside Financial Bank & Trust |
13F
|
Company |
0.01%
|
1,800
|
$674 | — | 31 Dec 2024 | |
| Zurcher Kantonalbank (Zurich Cantonalbank) |
13F
|
Company |
0.01%
|
1,653
|
$618 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
1,328
|
$496 | — | 31 Dec 2024 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0%
|
1,020
|
$381 | — | 31 Dec 2024 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0%
|
500
|
$187 | — | 31 Dec 2024 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
340
|
$127 | — | 31 Dec 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
259
|
$97 | — | 31 Dec 2024 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
113
|
$42 | — | 31 Dec 2024 | |
| Farther Finance Advisors, LLC |
13F
|
Company |
0%
|
95
|
$36 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
88
|
$33 | — | 31 Dec 2024 | |
| Point72 (DIFC) Ltd |
13F
|
Company |
0%
|
35
|
$13 | — | 31 Dec 2024 | |
| US BANCORP \DE\ |
13F
|
Company |
0%
|
33
|
$12 | — | 31 Dec 2024 | |
| Rashmi Agarwal |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,554,945
|
$187,267,747 | — | 03 Apr 2023 |
Institutional Holders of BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (BTAI) as of Q1 2025
As of 31 Mar 2025,
BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (BTAI) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
378,983 shares.
The largest 10 holders included
Murchinson Ltd., UBS Group AG, GOLDMAN SACHS GROUP INC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, Beacon Pointe Advisors, LLC, VANGUARD GROUP INC, WELLS FARGO & COMPANY/MN, Virtu Financial LLC, and BARCLAYS PLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2025 Across Filers
Q4 2025 holders
42
Q1 2025 holders
31
Holder diff
-11
| Investor | Q4 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.